BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 31075354)

  • 1. New molecular therapies for the treatment of hearing loss.
    Ma Y; Wise AK; Shepherd RK; Richardson RT
    Pharmacol Ther; 2019 Aug; 200():190-209. PubMed ID: 31075354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies for human hearing loss.
    Ajay E; Gunewardene N; Richardson R
    Expert Opin Biol Ther; 2022 Jun; 22(6):689-705. PubMed ID: 35485229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative Therapy Approaches and Encountered Problems in Sensorineural Hearing Loss.
    Kelleci K; Golebetmaz E
    Curr Stem Cell Res Ther; 2023; 18(2):186-201. PubMed ID: 36891922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based neurotrophin treatment supports long-term auditory neuron survival in the deaf guinea pig.
    Gillespie LN; Zanin MP; Shepherd RK
    J Control Release; 2015 Jan; 198():26-34. PubMed ID: 25481440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss.
    Kempfle JS; Nguyen K; Hamadani C; Koen N; Edge AS; Kashemirov BA; Jung DH; McKenna CE
    Bioconjug Chem; 2018 Apr; 29(4):1240-1250. PubMed ID: 29485861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophin gene augmentation by electrotransfer to improve cochlear implant hearing outcomes.
    Pinyon JL; von Jonquieres G; Crawford EN; Duxbury M; Al Abed A; Lovell NH; Klugmann M; Wise AK; Fallon JB; Shepherd RK; Birman CS; Lai W; McAlpine D; McMahon C; Carter PM; Enke YL; Patrick JF; Schilder AGM; Marie C; Scherman D; Housley GD
    Hear Res; 2019 Sep; 380():137-149. PubMed ID: 31301514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug delivery systems for inner ear protection and regeneration after hearing loss.
    Richardson RT; Wise AK; Andrew JK; O'Leary SJ
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1059-76. PubMed ID: 18817513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Cochlear Therapies.
    Wang J; Puel JL
    Physiol Rev; 2018 Oct; 98(4):2477-2522. PubMed ID: 30156495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in cochlear hair cell regeneration-A promising opportunity for the treatment of age-related hearing loss.
    Revuelta M; Santaolalla F; Arteaga O; Alvarez A; Sánchez-Del-Rey A; Hilario E
    Ageing Res Rev; 2017 Jul; 36():149-155. PubMed ID: 28414155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulating cell fate in the cochlea: a feasible therapy for hearing loss.
    Fujioka M; Okano H; Edge AS
    Trends Neurosci; 2015 Mar; 38(3):139-44. PubMed ID: 25593106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochlear Gene Therapy.
    Lustig L; Akil O
    Cold Spring Harb Perspect Med; 2019 Sep; 9(9):. PubMed ID: 30323014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating hearing disorders with cell and gene therapy.
    Gillespie LN; Richardson RT; Nayagam BA; Wise AK
    J Neural Eng; 2014 Dec; 11(6):065001. PubMed ID: 25420002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cool approach to reducing electrode-induced trauma: Localized therapeutic hypothermia conserves residual hearing in cochlear implantation.
    Tamames I; King C; Bas E; Dietrich WD; Telischi F; Rajguru SM
    Hear Res; 2016 Sep; 339():32-9. PubMed ID: 27260269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.
    Akil O; Blits B; Lustig LR; Leake PA
    Hum Gene Ther; 2019 Jan; 30(1):88-105. PubMed ID: 30183384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for the application of optical stimulation in the cochlea for the study and treatment of hearing loss.
    Richardson RT; Thompson AC; Wise AK; Needham K
    Expert Opin Biol Ther; 2017 Feb; 17(2):213-223. PubMed ID: 27960585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochlear gene therapy.
    Lustig LR; Akil O
    Curr Opin Neurol; 2012 Feb; 25(1):57-60. PubMed ID: 22157110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the optical cochlear implant: optogenetic approaches for hearing restoration.
    Dieter A; Keppeler D; Moser T
    EMBO Mol Med; 2020 Apr; 12(4):e11618. PubMed ID: 32227585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells and molecular strategies to restore hearing.
    Pauley S; Kopecky B; Beisel K; Soukup G; Fritzsch B
    Panminerva Med; 2008 Mar; 50(1):41-53. PubMed ID: 18427387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pharmacological intervention for treatment/prevention of hearing loss.
    Cotanche DA
    J Commun Disord; 2008; 41(5):421-43. PubMed ID: 18455177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of stem cell for the regeneration of spiral ganglion neurons.
    Mohammadian F; Eatemadi A; Daraee H
    Cell Mol Biol (Noisy-le-grand); 2017 Jan; 63(1):6-12. PubMed ID: 28234627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.